With Trial Approval, Medtronic Aims For Symplicity RF Catheter Launch In 2014
This article was originally published in The Gray Sheet
Executive Summary
With conditional FDA approval for its pivotal trial in hand, Medtronic says it is on track to launch its Symplicity renal nerve ablation catheter system for drug-resistant hypertension in the U.S. in 2014.